What is Dare Bioscience Profitability Rank?
Dare Bioscience has the Profitability Rank of 0.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1.
Operating Margin %
2.
Piotroski F-Score
3. Trend of the
Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Dare Bioscience's Operating Margin % for the quarter that ended in Mar. 2024 was -66,911.11%. As of today, Dare Bioscience's Piotroski F-Score is 0.
Competitive Comparison of Dare Bioscience's Profitability Rank
For the Biotechnology subindustry, Dare Bioscience's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dare Bioscience's Profitability Rank Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dare Bioscience's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Dare Bioscience's Profitability Rank falls into.
Dare Bioscience Profitability Rank Calculation
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Dare Bioscience has the Profitability Rank of 0.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
1. Operating Margin %
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Dare Bioscience's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2. Piotroski F-Score
Warning Sign:
Piotroski F-Score of 0 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Dare Bioscience has an F-score of 0. It is a bad or low score, which usually implies poor business operation.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Dare Bioscience (Dare Bioscience) Business Description
Traded in Other Exchanges
N/A
Address
3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Executives
| Sophia Nnenna Ononye-onyia |
director |
1270 AVE OF THE AMERICAS, 7TH FL - 1026, NEW YORK NY 10020 |
| Sabrina Martucci Johnson |
director, officer: Chef Executive Officer |
11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| John A Fair |
officer: Chief Strategy Officer |
C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| Cheryl R Blanchard |
director |
C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580 |
| Roger Hawley |
director |
3655 NOBEL DRIVE, SUITE 260, SAN DIEGO CA 92122 |
| Gregory W Matz |
director |
1 WHITE OAK WAY, NOVATO CA 94949 |
| Jessica D. Grossman |
director |
C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| Lisa Walters-hoffert |
officer: Chief Financial Officer |
C/O DARE BIOSCIENCE, INC., 10210 CAMPUS POINT DRIVE, SUITE 150, SAN DIEGO CA 92121 |
| Robin Joan Steele |
director |
3280 BAYSHORE BOULEVARD, BRISBANE CA 94005 |
| Scott Eliasof |
officer: SVP, Chief Scientific Officer |
C/O CERULEAN PHARMA INC., 35 GATEHOUSE DRIVE, WALTHAM MA 02451 |
| David R Walt |
director |
5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
| Adrian Senderowicz |
officer: SVP, Chief Medical Officer |
C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90024 |
| Stuart A Arbuckle |
director |
VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY ST., CAMBRIDGE MA 02139 |
| Alejandra Carvajal |
officer: VP, General Counsel |
C/O CERULEAN PHARMA INC., 840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE MA 02139 |
| James E Oneill |
officer: Principal Accounting Officer |
15 GREENBRIAR CIRCLE, ANDOVER MA 01810 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DARE has been successfully added to your